Citation: | SUN Li jun, ZHANG Mei, ZHENG Ying. Effects of Mifepristone on Cell Proliferation of Human Ovarian Epithelial Carcinoma Cell Line HO_(8910) in Vitro[J]. Cancer Research on Prevention and Treatment, 2004, 31(02): 88-89. DOI: 10.3971/j.issn.1000-8578.14 |
[1] | YANG Ming, FENG Yanlin, LIU Dejun, YU Fengwen, HUANG Kemin, LI Wen, XIAN Weijun, LU Shengnan, WANG Ying. Correlation Between Ki67 Expression and 18F-FDG PET/CT SUVmax in Patient with Diffuse Large B-cell Lymphoma and Their Application in Therapeutic Effect Evaluation[J]. Cancer Research on Prevention and Treatment, 2018, 45(12): 1004-1008. DOI: 10.3971/j.issn.1000-8578.2018.18.0652 |
[2] | ZHONG Wei-ming, MA Li-ping, CAI Yong-lin, LIANG Wei, CHEN Wan-sheng, HUANG Zhuo, YU Hong, TAN Bi-fang. Relationship between Expression of Ki-67 Protein and Radiosensitivity of Nasopharyngeal Carcinoma[J]. Cancer Research on Prevention and Treatment, 2010, 37(02): 195-196. DOI: 10.3971/j.issn.1000-8578.2010.02.019 |
[3] | DENG Wankai, CHEN Jian, ZHEN G Hongmei. Expression of Smac and Ki67 in Thyroid Carcinoma and Its Cl inical Signif icance[J]. Cancer Research on Prevention and Treatment, 2008, 35(11): 800-802. DOI: 10.3971/j.issn.1000-8578.2242 |
[4] | HE Yan-jiao, LIU Zhao-xia, LI Hong-li, YU Jin, LI Guang. Expression and Significance of E-cadherin and Ki-67 in Colorectal Carcinoma[J]. Cancer Research on Prevention and Treatment, 2007, 34(09): 699-702. DOI: 10.3971/j.issn.1000-8578.2529 |
[5] | DUAN Bo, ZHAO Hong-yang, LI Xin-jian, HU Xue-bin, TU Han-jun. Expression and Relationship between CD44 and Ki-67 in Invasive Pituitary Adenoma[J]. Cancer Research on Prevention and Treatment, 2006, 33(07): 490-492,. DOI: 10.3971/j.issn.1000-8578.2294 |
[6] | LI Hong ling, SUN Bing zhong, MA Fu cheng. Significance and Expression of survivin Protein and Ki67 in Non-hodgkin′s Lymphoma[J]. Cancer Research on Prevention and Treatment, 2004, 31(02): 70-72. DOI: 10.3971/j.issn.1000-8578.20 |
[7] | SHI Xiao-yan, HU Guo-qing, CAO Rong-hua. The significance of the expression of Ki67 antigen in nasopharyngeal carcinoma[J]. Cancer Research on Prevention and Treatment, 2004, 31(01): 4-6. DOI: 10.3971/j.issn.1000-8578.2043 |
[8] | LI Zhi-qiang, YUAN Xian-hou, YUAN Zhong-hui. Clinical implications of VEGF and Ki-67 expression in astrocytic tumor patients[J]. Cancer Research on Prevention and Treatment, 2003, 30(06): 462-463. DOI: 10.3971/j.issn.1000-8578.2908 |
[9] | CAI Xin-ran, HUANG Chang-yu, Yang Fa-duan. The Expression and Biologic Significanc e of K167 Antigen and TGF β1 in Human Hepatic Cholangiocarcinoma.[J]. Cancer Research on Prevention and Treatment, 2000, 27(04): 247-249. DOI: 10.3971/j.issn.1000-8578.1402 |
[10] | Wu Weicheng, . Prognostic value of Ki-67 Labeling Index in Renal Cell Carcinoma[J]. Cancer Research on Prevention and Treatment, 1998, 25(3): 178-180. |